BNTC Benitec Biopharma Limited gains 31% Jul 16, 2018 priceSeries Monday, July 16, 2018 0 Comment Developing gene therapies for hepatitis C based on RNA interference.http://www.priceseries.com/trade/BNTC-Benitec-Biopharma-Limited-stock-gains-31-percent-a-Trade-Record-by-priceSeries-2018070320180716.html Posted by : priceSeries Monday, July 16, 2018 Subscribe by Email Follow Updates Articles from This Blog via Email
No Comments